home / stock / nvno / nvno quote
Last: | $6.06 |
---|---|
Change Percent: | -1.94% |
Open: | $6.31 |
Close: | $6.06 |
High: | $6.48 |
Low: | $6.03 |
Volume: | 78,110 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.06 | $6.31 | $6.06 | $6.48 | $6.03 | 78,110 | 07-16-2024 |
$6.19 | $6.09 | $6.19 | $6.46 | $5.86 | 80,493 | 07-15-2024 |
$5.99 | $5.97 | $5.99 | $6.1 | $5.86 | 49,281 | 07-12-2024 |
$5.95 | $5.9 | $5.95 | $6.1 | $5.83 | 76,406 | 07-11-2024 |
$5.84 | $5.21 | $5.84 | $5.84 | $5.0701 | 121,275 | 07-10-2024 |
$5.13 | $4.95 | $5.13 | $5.27 | $4.95 | 37,205 | 07-09-2024 |
$4.98 | $5.21 | $4.98 | $5.2999 | $4.98 | 64,928 | 07-08-2024 |
$5.21 | $5.05 | $5.21 | $5.21 | $5.05 | 16,361 | 07-05-2024 |
$5.05 | $5.13 | $5.05 | $5.1886 | $5.05 | 24,527 | 07-04-2024 |
$5.05 | $5.13 | $5.05 | $5.1886 | $5.05 | 24,527 | 07-03-2024 |
$5.07 | $5.18 | $5.07 | $5.26 | $4.805 | 53,120 | 07-02-2024 |
$5.12 | $5.27 | $5.12 | $5.335 | $5.0802 | 40,938 | 07-01-2024 |
$5.25 | $5.21 | $5.25 | $5.25 | $4.93 | 85,581 | 06-28-2024 |
$5.17 | $5.01 | $5.17 | $5.22 | $5.01 | 38,674 | 06-27-2024 |
$5.15 | $5.11 | $5.15 | $5.2 | $4.95 | 54,607 | 06-26-2024 |
$5.2 | $5.42 | $5.2 | $5.46 | $4.99 | 67,988 | 06-25-2024 |
$5.34 | $4.99 | $5.34 | $5.69 | $4.79 | 196,179 | 06-24-2024 |
$5 | $4.61 | $5 | $5 | $4.29 | 2,511,192 | 06-21-2024 |
$4.67 | $4.66 | $4.67 | $4.81 | $4.65 | 65,043 | 06-20-2024 |
$4.7 | $4.8 | $4.7 | $4.89 | $4.7 | 30,222 | 06-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
enVVeno Medical Corp Com Company Name:
NVNO Stock Symbol:
NASDAQ Market:
enVVeno Medical Corp Com Website:
Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Thursday, June 27 th at 4:00 PM ET IRVINE, CA / ACCESSWIRE / June 25, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatmen...
91% of Venous Ulcer Patients Evaluated at One Year Have Either Fully Healed Ulcers or Ulcers That Have Improved 100% of Venous Ulcers with a Duration of One Year or Less Prior to VenoValve Surgery Have Fully Healed 89% of Venous Ulcers with a Duration of More Than One Year Prior to Veno...
IRVINE, CA / ACCESSWIRE / June 17, 2024 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced that new interim venous ulcer healing data from the VenoValve U.S. pivotal trial will be ...